MiniMed Group, Inc. (MMED)

MiniMed Group, Inc. (MMED) is a diabetes technology company headquartered in Northridge, California, formed through Medtronic's separation of its diabetes business into a standalone public company. The MiniMed name has been associated with insulin pumps since the 1980s.

The company develops, manufactures and sells insulin delivery systems and continuous glucose monitoring products for people with diabetes who use intensive insulin therapy. Its flagship offerings include the MiniMed 780G automated insulin delivery system, which adjusts insulin dosing based on sensor readings, and glucose sensors such as Simplera. It also provides the InPen smart insulin pen, infusion sets and other supplies, and software that helps patients and clinicians track and manage glucose data.

MiniMed sells its products in the United States and many international markets, earning a substantial share of revenue from recurring sales of consumables used with its devices.